Open-Angle Glaucoma: Clinical Trials

17 trials for Open-Angle Glaucoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 3 terminated, 2 unknown, 1 active not recruiting. 17 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable17Completed 9, Terminated 3, Unknown 2, Active not recruiting 1, Recruiting 1, Withdrawn 1

Follow Open-Angle Glaucoma: new trials by email Literature Review of Open-Angle Glaucoma trials Research Report on Open-Angle Glaucoma

Trials (filtered) newest first · largest first

All 17 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
This Follow-up Extension Study is Aimed to Monitor the Long-term IOP-lowering Performance/Efficacy and Safety of the MINT® Procedure in Open Angle Glaucoma Eyes.
MINT Minimally Invasive Nasal Trabeculostomy - Glaucoma, Ocular Hypertension
Not applicableCompletedSanoculis Ltd472025-06-162026-10-15
Vitamin Mix (B6, B9, B12, And Choline) For Glaucoma Patients
Vitamin B-mix, Standard Care - Open-angle Glaucoma, Pseudoexfoliation Glaucoma
Not applicableRecruitingKarolinska Institutet802025-03-312025-04-29
Selective, Micropulse and Pattern Laser Trabeculoplasty in Medically Treated Open-angle Glaucoma.
Selective laser trabeculoplasty, Micropulse laser trabeculoplasty, Pattern laser trabeculoplasty - Open-Angle Glaucoma, Ocular Hypertension
Not applicableCompletedUniversity of Udine902025-02-012026-08-10
Efficacy and Safety of Trabecular Meshwork Microstent Drainage System ( MicroCOGO )
Trabecular Meshwork Microstent Drainage System, phacoemulsification - Open-angle Glaucoma, Cataract
Not applicableActive not recruitingHealthguard Biomed2072022-10-192024-12-19
Effect of MEMOPTIC on Visual Field of Patients Followed for a Chronic Open-angle Glaucoma
MEMOPTIC, usual treatment of glaucoma - Open-angle Glaucoma, Visual Field
Not applicableTerminatedCentre Hospitalier Universitaire, Amiens152020-09-212026-06-12
Hydrus Microstent for Refractory Open-Angle Glaucoma
Hydrus Microstent, Ophthalmic surgery - Open-angle Glaucoma
Not applicableCompletedIvantis, Inc.2172017-08-012026-01-14
Safety and Effectiveness of the Sight Sciences VISCO™360 Versus SLT in Primary Open Angle Glaucoma
VISCO360 ab interno canaloplasty surgery, Selective Laser Trabeculoplasty (SLT) - Open-Angle Glaucoma
Not applicableTerminatedSight Sciences, Inc.292017-01-232025-11-14
aICP in Glaucoma and Papilledema
Non-invasive ICP measurement (Vittamed 305) - Open-angle Glaucoma, Papilledema
Not applicableUnknownKantonsspital Aarau602015-04-012015-04-08
The Expression of Matrix Metalloproteinase 13, Tissue Inhibitor of Metalloproteinases 3, and Calcium-sensing Receptor in Human Trabecular Meshwork
trabeculectomy - Open-angle Glaucoma
Not applicableCompletedLv Yingjuan602013-07-012017-01-10
Open-angle Glaucoma Subjects on One Topical Hypotensive Medication Randomized to Treatment With One or Two Trabecular Micro-bypass Stents in Conjunction With Cataract Surgery
One iStent, Two iStent - Open-angle Glaucoma
Not applicableCompletedGlaukos Corporation792011-09-012022-08-31
Open-angle Glaucoma Subjects on One Ocular Hypotensive Medication Randomized to Treatment With Two Trabecular Micro-bypass Stents or Selective Laser Trabeculoplasty
iStent, SLT - Open-angle Glaucoma
Not applicableCompletedGlaukos Corporation802011-09-012022-08-31
Open-Angle Glaucoma Subjects With One Prior Trabeculectomy Treated Concurrently With One Suprachoroidal Stent and Two Trabecular Micro-bypass Stents
iStent and iStent supra - Open-Angle Glaucoma
Not applicableCompletedGlaukos Corporation792011-09-012022-09-07
Safety and Efficacy of Bimatoprost Timolol Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension
0.03% Bimatoprost/0.5% Timolol Ophthalmic Solution, 0.03% Bimatoprost Ophthalmic Solution and 0.5% Timolol Ophthalmic Solution - Open-angle Glaucoma, Ocular Hypertension
Not applicableCompletedAllergan2352010-02-012019-04-17
Comparative Study of Ologen Collagen Matrix Versus Mitomycin-C in Trabeculectomy: A Study in Germany
Use of ologen Collagen Matrix in trabeculectomy, Use of Mitomycin-C in trabeculectomy - Open-angle Glaucoma
Not applicableUnknownAeon Astron Europe B.V.402009-11-012011-05-09
The Effects of Cosopt® Vs Xalacom® on Ocular Hemodynamics and Intraocular Pressure (IOP) in Primary Open-angle Glaucoma (POAG)
Dorzolamide+Timolol Maleate0.5%, Latanoprost+Timolol Maleate0.5%+Lytears - Open-Angle Glaucoma, Ocular Hypertension
Not applicableWithdrawnMeir Medical Center2008-12-012012-03-16
PASCAL Trabeculoplasty
Patter Scan Laser System (OptiMedica, Santa Clara, CA, USA) - Open-Angle Glaucoma
Not applicableTerminatedAsociación para Evitar la Ceguera en México242007-12-012024-05-30
A Study of the iStent in Combo With Cataract Surgery in Newly Diagnosed Open Angle Glaucoma or OH Patients.
Glaucoma Surgery, cataract surgery only - Open-Angle Glaucoma
Not applicableCompletedGlaukos Corporation472005-02-012018-03-09

Narrower conditions

Glaucoma, Open-Angle (17)  ·  Glaucoma (5)  ·  Ocular Hypertension (4)  ·  Cataract (2)  ·  Exfoliation Syndrome (1)  ·  Papilledema (1)

Broader conditions

Eye Diseases (17)  ·  Ocular Hypertension (13)  ·  Glaucoma (12)  ·  Lens Diseases (2)  ·  Cranial Nerve Diseases (1)  ·  Iris Diseases (1)  ·  Nervous System Diseases (1)  ·  Optic Nerve Diseases (1)  ·  Uveal Diseases (1)

Interventions

Phacoemulsification (2)  ·  Trabeculectomy (2)  ·  Ophthalmologic Surgical Procedures (1)  ·  Standard of Care (1)  ·  dorzolamide-timolol combination (1)

Sponsors

Glaukos Corporation (4)  ·  Aeon Astron Europe B.V. (1)  ·  Allergan (1)  ·  Asociación para Evitar la Ceguera en México (1)  ·  Centre Hospitalier Universitaire, Amiens (1)  ·  Healthguard Biomed (1)  ·  Ivantis, Inc. (1)  ·  Kantonsspital Aarau (1)  ·  Karolinska Institutet (1)  ·  Lv Yingjuan (1)  ·  Meir Medical Center (1)  ·  Sanoculis Ltd (1)  ·  Sight Sciences, Inc. (1)  ·  University of Udine (1)

Countries

Armenia (4)  ·  China (3)  ·  Germany (2)  ·  Spain (2)  ·  United States (2)  ·  Austria (1)  ·  Colombia (1)  ·  France (1)  ·  Israel (1)  ·  Italy (1)  ·  Mexico (1)  ·  Netherlands (1)  ·  Philippines (1)  ·  Sweden (1)  ·  Switzerland (1)

Top investigators

Lilit A Voskanyan, MD, PhD (3)  ·  Adi Abulafia, MD (1)  ·  Anne-Marie Ripley (1)  ·  Claire Iscar, MD (1)  ·  Daniele Veritti (1)  ·  Felix Gil Carrasco, MD (1)  ·  Hanspeter Killer, MD (1)  ·  Rune Brautaset, Professor of Optometry (1)  ·  Thomas Dietlein, MD (1)  ·  Xinghuai Sun, Doctor (1)

Results publications

PMID 35943114, PMID 20207977, PMID 29476443, PMID 36912740, PMID 41084053

NIH funding

2023 (1)